Filing Details
- Accession Number:
- 0001127602-11-000974
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-05 14:45:53
- Reporting Period:
- 2011-01-04
- Filing Date:
- 2011-01-05
- Accepted Time:
- 2011-01-05 14:45:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1504983 | E. Robert Gagnon | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Chief Acct Officer Vp & Contr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-01-04 | 796 | $66.57 | 10,814 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-01-04 | 1,554 | $49.59 | 12,368 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-01-04 | 1,554 | $66.58 | 10,814 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-01-04 | 1,700 | $40.63 | 12,514 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-01-04 | 1,700 | $66.55 | 10,814 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-01-04 | 1,053 | $49.65 | 11,867 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-01-04 | 1,053 | $66.57 | 10,814 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-01-04 | 1,554 | $0.00 | 1,554 | $49.59 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-01-04 | 1,700 | $0.00 | 1,700 | $40.63 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-01-04 | 1,053 | $0.00 | 1,053 | $49.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,556 | 2018-10-01 | No | 4 | M | Direct | |
| 0 | 2015-10-31 | No | 4 | M | Direct | |
| 3,162 | 2019-02-24 | No | 4 | M | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $66.33 (low) $66.91 (high).
- This represents the weighted average price for shares sold at a range between $66.35 (low) $67.00 (high).
- This represents the weighted average price for shares sold at a range between $66.33 (low) $67.00 (high).
- This represents the weighted average price for shares sold at a range between $66.33 (low) $66.98 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 10/01/2008.
- The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 10/31/2005.
- The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.
Billionaire Hedge Funds
